Hassett, Michael
Dias, Samira
Cronin, Christine
Schrag, Deborah
McCleary, Nadine
Simpson, Jaclyn
Poirier-Shelton, Tiana
Bian, Jessica
Reich, James
Dizon, Don
Begnoche, Megan
Jenkins, Hannah Hazard
Tasker, Laura
Wong, Sandra
Pearson, Loretta
Paudel, Roshan
Osarogiagbon, Raymond U.
Funding for this research was provided by:
National Cancer Institute, United States (UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080, UM1CA233080)
Article History
Received: 19 January 2024
Accepted: 3 September 2024
First Online: 12 November 2024
Declarations
:
: The Western Institutional Review Board (WIRB) approved the protocol as a minimal risk research study on November 25, 2018 (protocol #20182593) with a waiver of individual authorization for release of health data and a waiver of informed consent.
: Not applicable.
: The authors declare no competing interests.